Solutions

Streamline Medical Device Post-Market Surveillance, Compliance and Research

  • Automated data extraction and stratified EHR analysis by indication.
  • Real-time safety and performance monitoring.
  • Longitudinal outcomes tied to specific devices.
  • Immediate access to known patient cohorts for focused studies.

  • Utilize real-world clinical data to support marketing strategies.
  • Provide safety and efficacy evidence for healthcare providers and patients.
  • Tailor marketing materials with validated clinical data insights.
  • Enhance competitive edge by substantiating performance claims.

  • Utilize real-world clinical data to support marketing strategies.
  • Provide safety and efficacy evidence for healthcare providers and patients.
  • Tailor marketing materials with validated clinical data insights.
  • Enhance competitive edge by substantiating performance claims.

  • Reduce research and development timelines through efficient data utilization.
  • Optimize study designs and target cohort stratification.
  • Mine unstructured EHR data using advanced Natural Language Processing AI.
  • Drive iterative design innovation with data-informed product development insights.

  • Address EU MDR and FDA compliance demands with regulation-grade real-world evidence (RWE).
  • Reduce regulatory submission time and cost by up to 60%.
  • Demonstrate data relevance and reliability with device agnostic validation studies.
  • Economize data management and evidence generation with 3Aware's fit-for-purpose platform.

"The EU Legislator now expects higher requirements for sufficient clinical data of all medical devices, ensuring acceptable safety and performance of a device over its expected lifetime; regardless of risk class, complexity, or invasiveness level.

We cannot keep using traditional methods and must instead think differently by using new methods of data linkage for analysis of device-specific electronic patient records; therefore, 3Aware is the real hope for the various frustrated economic operators."

Dr. Bassil Akra

CEO of AKRA TEAM GmbH
Contributing Author to the EU MDR Guidance

  • Ongoing reporting of device utilization and clinical outcomes, including Patient Reported Outcome Measures (PROMs) and EHR imaging.
  • Active surveillance of devices for risk signals and new indications.
  • Supports continuous improvement and compliance initiatives.
  • Scalable solutions for longitudinal data analysis across patient population.

  • Monitor adverse effects and device efficacy in real-world settings.
  • Utilize aiSurveillance for advanced analytics and reporting.
  • Identify failure patterns and reduce risks associated with long-term device use.
  • Deliver robust evidence for ongoing safety evaluations and quality assurance.
  • Compare new products with legacy devices and market benchmarks.